Inspire Medical Systems, Inc. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested
Inspire Medical Systems, Inc. (INSP) reported Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested of $39.30 million for the 6-month period ending 2022-06-30, per its 10-Q filed 2022-08-02.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure › Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value
us-gaap:SharebasedCompensationArrangementBySharebasedPaymentAwardEquityInstrumentsOtherThanOptionsAggregateIntrinsicValueVested · last filed 2022-08-02
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2022-06-30 was $9.48M, a 23.01% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2022-03-31 was $29.82M, a 21.38% increase year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2021-12-31 was $11.18M, a 42.41% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for the quarter ending 2021-09-30 was $14.90M, a 10.27% decline year-over-year.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2021 was $58.36M, a 6.46% increase from fiscal 2020.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2020 was $54.82M, a 55.28% increase from fiscal 2019.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2019 was $35.30M, a 380.14% increase from fiscal 2018.
- Inspire Medical Systems, Inc. share-based compensation arrangement by share-based payment award, equity instruments other than options, aggregate intrinsic value, vested for fiscal 2018 was $7.35M.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Aggregate Intrinsic Value, Vested 12 month as first filed |
|---|---|---|---|---|---|
| 2022-06-30 | $9.48M derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-02 | $39.30M 10-Q · filed 2022-08-02 | $50.49M derived: sum of 3 quarters · filed 2022-08-02 | $65.39M derived: sum of 4 quarters · filed 2022-08-02 | |
| 2022-03-31 | $29.82M 10-Q · filed 2022-05-03 | $41.00M derived: sum of 2 quarters · filed 2022-05-03 | $55.90M derived: sum of 3 quarters · filed 2022-05-03 | $63.61M derived: sum of 4 quarters · filed 2022-05-03 | |
| 2021-12-31 | $11.18M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $26.08M derived: sum of 2 quarters · filed 2022-02-15 | $33.79M derived: sum of 3 quarters · filed 2022-02-15 | $58.36M 10-K · filed 2022-02-15 | |
| 2021-09-30 | $14.90M derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-02 | $22.61M derived: sum of 2 quarters · filed 2021-11-02 | $47.18M 10-Q · filed 2021-11-02 | $66.60M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2021-06-30 | $7.71M derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-03 | $32.28M 10-Q · filed 2021-08-03 | $51.70M derived: sum of 3 quarters · filed 2022-02-15 | $68.30M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2021-03-31 | $24.57M 10-Q · filed 2021-05-04 | $43.99M derived: sum of 2 quarters · filed 2022-02-15 | $60.59M derived: sum of 3 quarters · filed 2022-02-15 | $65.61M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-12-31 | $19.42M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | $36.03M derived: sum of 2 quarters · filed 2022-02-15 | $41.04M derived: sum of 3 quarters · filed 2022-02-15 | $54.82M 10-K · filed 2022-02-15 | |
| 2020-09-30 | $16.61M derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-02 | $21.62M derived: sum of 2 quarters · filed 2020-11-02 | $35.40M 10-Q · filed 2020-11-02 | $9.48M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-06-30 | $5.01M derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-04 | $18.80M 10-Q · filed 2020-08-04 | -$7.13M derived: sum of 3 quarters · filed 2022-02-15 | -$11.10M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2020-03-31 | $13.78M 10-Q · filed 2020-05-05 | -$12.14M derived: sum of 2 quarters · filed 2022-02-15 | -$16.12M derived: sum of 3 quarters · filed 2022-02-15 | -$21.32M derived: sum of 4 quarters · filed 2022-02-15 | |
| 2019-12-31 | -$25.92M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-15 | -$29.90M derived: sum of 2 quarters · filed 2022-02-15 | -$35.10M derived: sum of 3 quarters · filed 2022-02-15 | $35.30M 10-K · filed 2022-02-15 | |
| 2019-09-30 | -$3.98M derived: 10-Q 9 month − 10-Q 6 month · filed 2019-11-05 | -$9.18M derived: sum of 2 quarters · filed 2019-11-05 | $61.23M 10-Q · filed 2019-11-05 | $15.61M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-06-30 | -$5.20M derived: 10-Q 6 month − 10-Q 3 month · filed 2019-08-06 | $65.20M 10-Q · filed 2019-08-06 | $19.58M derived: sum of 3 quarters · filed 2021-02-24 | $29.21M derived: sum of 4 quarters · filed 2021-02-24 | |
| 2019-03-31 | $70.41M 10-Q · filed 2019-05-07 | $24.79M derived: sum of 2 quarters · filed 2021-02-24 | $34.42M derived: sum of 3 quarters · filed 2021-02-24 | ||
| 2018-12-31 | -$45.62M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-24 | -$35.99M derived: sum of 2 quarters · filed 2021-02-24 | $7.35M 10-K · filed 2021-02-24 | $52.80M 10-K · filed 2019-02-26 | |
| 2018-09-30 | $9.63M derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-06 | $52.98M 10-Q · filed 2018-11-06 | |||
| 2018-06-30 | $43.34M 10-Q · filed 2018-08-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| NovoCure Ltd (NVCR) | $1.886B | -11.87 | |
| LEMAITRE VASCULAR INC (LMAT) | United States | $1.848B | 33.37 |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| KESTRA MEDICAL TECHNOLOGIES, LTD. (KMTS) | United States | $1.535B | -9.02 |
| Alphatec Holdings, Inc. (ATEC) | United States | $1.531B | -12.14 |
| INTEGRA LIFESCIENCES HOLDINGS CORP (IART) | United States | $1.234B | -193.02 |
| ARTIVION, INC. (AORT) | United States | $1.123B | -345.09 |
| IRADIMED CORP (IRMD) | United States | $1.089B | 52.92 |
| TANDEM DIABETES CARE INC (TNDM) | United States | $1.059B | -16.57 |
| PROCEPT BioRobotics Corp (PRCT) | United States | $1.001B | -11.77 |